stock
Alnylam Pharmaceuticals Inc
NASDAQ | ALNY
408.77
USD
$0.00
(0.00%
)At Close (As of Dec 10, 2025)
$56.81B
Market Cap
1433.4
P/E Ratio
0.3
EPS
$495.55
52 Week High
$205.87
52 Week Low
HEALTHCARE
Sector
ALNY Chart
Recent Chart
Price Action
ALNY Technicals
ALNY Earnings
Yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $1.9B |
| Total Revenue | $2.2B |
| Cost Of Revenue | $323M |
| Costof Goods And Services Sold | $323M |
| Operating Income | -$177M |
| Selling General And Administrative | $976M |
| Research And Development | $1.1B |
| Operating Expenses | $2.1B |
| Investment Income Net | - |
| Net Interest Income | -$20M |
| Interest Income | $122M |
| Interest Expense | $142M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $57M |
| Income Before Tax | -$377M |
| Income Tax Expense | -$99M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$278M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$236M |
| Ebitda | -$179M |
| Net Income | -$278M |
Revenue & Profitability
Earnings Performance
ALNY Financials
yearly Cash Flow (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Operating Cashflow | -$8.3M |
| Payments For Operating Activities | - |
| Proceeds From Operating Activities | - |
| Change In Operating Liabilities | - |
| Change In Operating Assets | - |
| Depreciation Depletion And Amortization | $57M |
| Capital Expenditures | $34M |
| Change In Receivables | - |
| Change In Inventory | $14M |
| Profit Loss | - |
| Cashflow From Investment | -$117M |
| Cashflow From Financing | $294M |
| Proceeds From Repayments Of Short Term Debt | - |
| Payments For Repurchase Of Common Stock | - |
| Payments For Repurchase Of Equity | - |
| Payments For Repurchase Of Preferred Stock | - |
| Dividend Payout | - |
| Dividend Payout Common Stock | - |
| Dividend Payout Preferred Stock | - |
| Proceeds From Issuance Of Common Stock | - |
| Proceeds From Issuance Of Long Term Debt And Capital Securities Net | - |
| Proceeds From Issuance Of Preferred Stock | - |
| Proceeds From Repurchase Of Equity | - |
| Proceeds From Sale Of Treasury Stock | - |
| Change In Cash And Cash Equivalents | - |
| Change In Exchange Rate | - |
| Net Income | -$278M |
yearly Income Statement (As of Dec 31, 2024)
| Field | Value (USD) |
|---|---|
| Gross Profit | $1.9B |
| Total Revenue | $2.2B |
| Cost Of Revenue | $323M |
| Costof Goods And Services Sold | $323M |
| Operating Income | -$177M |
| Selling General And Administrative | $976M |
| Research And Development | $1.1B |
| Operating Expenses | $2.1B |
| Investment Income Net | - |
| Net Interest Income | -$20M |
| Interest Income | $122M |
| Interest Expense | $142M |
| Non Interest Income | - |
| Other Non Operating Income | - |
| Depreciation | - |
| Depreciation And Amortization | $57M |
| Income Before Tax | -$377M |
| Income Tax Expense | -$99M |
| Interest And Debt Expense | - |
| Net Income From Continuing Operations | -$278M |
| Comprehensive Income Net Of Tax | - |
| Ebit | -$236M |
| Ebitda | -$179M |
| Net Income | -$278M |
ALNY News
ALNY Profile
Alnylam Pharmaceuticals Inc Profile
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Alnylam Pharmaceuticals, Inc. is a pioneering biopharmaceutical company headquartered in Cambridge, Massachusetts, specializing in the development and commercialization of transformative RNA interference (RNAi) therapeutics aimed at addressing genetic diseases. The company boasts a robust pipeline of innovative RNAi-based therapies and has made significant strides in the market, including the successful launch of its first commercial product. With a steadfast commitment to scientific excellence and the advancement of medicine, Alnylam is positioned as a leader in the biopharmaceutical sector, striving to redefine treatment paradigms for both rare and prevalent diseases.
LPTX +368.57%
$2.05
MNTS +34.80%
$1.02
PAVS -15.50%
$0.03
VHAI -25.00%
$0.00
AXDX -61.36%
$0.03
NVDA -1.31%
$182.54
IRBT +34.41%
$4.74
ADAP -15.14%
$0.05
IBIO +43.24%
$3.18
SOND -23.45%
$0.12
RMBL +60.50%
$3.21
LNW -3.71%
$86.22
ADD -25.47%
$0.05
SRM +53.27%
$10.30
BNKK
-34.66%
$0.14
ASST -4.56%
$0.97
WBD +3.57%
$29.27
MTSR -0.35%
$70.50
ABEV -2.02%
$2.42
INTC -2.04%
$39.67
NFLX -1.99%
$94.77
AFMD -34.94%
$0.18
TSLA +0.09%
$445.59
DNN -3.10%
$2.65
PLUG 0.00%
$2.21
UBER -6.40%
$83.36
BYND +3.60%
$1.30
TE +11.79%
$6.73
ATPC -90.50%
$0.12
SLM -14.95%
$26.23
GRYP -10.38%
$1.38
HPE +1.05%
$25.03
NCLH -2.04%
$18.72
MODV -25.22%
$0.43
RXRX -1.03%
$4.77
RIG -3.81%
$4.28
ADVB -5.59%
$0.34
GPK -8.66%
$14.23
NOK +0.48%
$6.18
EXK +4.48%
$8.86
ONDS -5.03%
$8.76
CHR -1.78%
$0.04
SOFI +1.27%
$27.17
POM
-84.68%
$0.83
SPCE -16.26%
$3.81
TWOH
+16.66%
$0.00
BMNR
-0.03%
$39.19
KITT +9.44%
$1.16
JBLU +0.20%
$4.96
AAL -1.36%
$14.82
IQ -1.93%
$2.03
BBGI +186.66%
$11.61
BMNU
+0.79%
$10.79
SHOT -74.37%
$0.39
DVLT -7.00%
$1.46
PFE +0.50%
$25.45
ZAPP -46.30%
$0.15
CFLT +0.38%
$30.01
MARA -2.89%
$11.89
PLTD -2.98%
$6.33
CRWV
-2.73%
$88.18
F +0.38%
$13.13
PFSA
-6.95%
$0.18
IONQ +0.14%
$54.44
SOLT +9.15%
$8.35
HLN -0.95%
$9.31
CVS +2.23%
$78.24
PLTR +2.14%
$185.73
AMZN +1.34%
$230.99
CARR -0.35%
$52.84
COMP +4.03%
$10.84
RDW +6.89%
$7.29
BTE -0.64%
$3.07
TNFA -4.92%
$6.56
CHWY +1.07%
$35.21
BAC +0.55%
$53.83
IVP -19.74%
$0.06
SPR +0.22%
$39.50
GOOGL +0.24%
$317.86
MSFT -2.14%
$481.48
CRCA
+11.32%
$5.31
BLNK -5.65%
$0.94
BDRX +24.54%
$5.06
WVE -3.42%
$20.58
IREN -4.39%
$44.78
T -0.21%
$24.45
SONN -59.35%
$1.26
HPQ +1.23%
$25.38
KDLY +3.49%
$0.46
RF +0.37%
$26.44
SBUX -1.35%
$82.28
ORCL -0.71%
$219.95
SNAP -2.65%
$7.71
VTRS +0.90%
$11.19
QUBT -6.27%
$12.38
KVUE +0.59%
$17.12
RGTI -4.97%
$26.81
CGC +2.67%
$1.16
SMR -4.59%
$20.34
SBET +4.88%
$11.60
LPTX +368.57%
$2.05
MNTS +34.80%
$1.02
PAVS -15.50%
$0.03
VHAI -25.00%
$0.00
AXDX -61.36%
$0.03
NVDA -1.31%
$182.54
IRBT +34.41%
$4.74
ADAP -15.14%
$0.05
IBIO +43.24%
$3.18
SOND -23.45%
$0.12
RMBL +60.50%
$3.21
LNW -3.71%
$86.22
ADD -25.47%
$0.05
SRM +53.27%
$10.30
BNKK
-34.66%
$0.14
ASST -4.56%
$0.97
WBD +3.57%
$29.27
MTSR -0.35%
$70.50
ABEV -2.02%
$2.42
INTC -2.04%
$39.67
NFLX -1.99%
$94.77
AFMD -34.94%
$0.18
TSLA +0.09%
$445.59
DNN -3.10%
$2.65
PLUG 0.00%
$2.21
UBER -6.40%
$83.36
BYND +3.60%
$1.30
TE +11.79%
$6.73
ATPC -90.50%
$0.12
SLM -14.95%
$26.23
GRYP -10.38%
$1.38
HPE +1.05%
$25.03
NCLH -2.04%
$18.72
MODV -25.22%
$0.43
RXRX -1.03%
$4.77
RIG -3.81%
$4.28
ADVB -5.59%
$0.34
GPK -8.66%
$14.23
NOK +0.48%
$6.18
EXK +4.48%
$8.86
ONDS -5.03%
$8.76
CHR -1.78%
$0.04
SOFI +1.27%
$27.17
POM
-84.68%
$0.83
SPCE -16.26%
$3.81
TWOH
+16.66%
$0.00
BMNR
-0.03%
$39.19
KITT +9.44%
$1.16
JBLU +0.20%
$4.96
AAL -1.36%
$14.82
IQ -1.93%
$2.03
BBGI +186.66%
$11.61
BMNU
+0.79%
$10.79
SHOT -74.37%
$0.39
DVLT -7.00%
$1.46
PFE +0.50%
$25.45
ZAPP -46.30%
$0.15
CFLT +0.38%
$30.01
MARA -2.89%
$11.89
PLTD -2.98%
$6.33
CRWV
-2.73%
$88.18
F +0.38%
$13.13
PFSA
-6.95%
$0.18
IONQ +0.14%
$54.44
SOLT +9.15%
$8.35
HLN -0.95%
$9.31
CVS +2.23%
$78.24
PLTR +2.14%
$185.73
AMZN +1.34%
$230.99
CARR -0.35%
$52.84
COMP +4.03%
$10.84
RDW +6.89%
$7.29
BTE -0.64%
$3.07
TNFA -4.92%
$6.56
CHWY +1.07%
$35.21
BAC +0.55%
$53.83
IVP -19.74%
$0.06
SPR +0.22%
$39.50
GOOGL +0.24%
$317.86
MSFT -2.14%
$481.48
CRCA
+11.32%
$5.31
BLNK -5.65%
$0.94
BDRX +24.54%
$5.06
WVE -3.42%
$20.58
IREN -4.39%
$44.78
T -0.21%
$24.45
SONN -59.35%
$1.26
HPQ +1.23%
$25.38
KDLY +3.49%
$0.46
RF +0.37%
$26.44
SBUX -1.35%
$82.28
ORCL -0.71%
$219.95
SNAP -2.65%
$7.71
VTRS +0.90%
$11.19
QUBT -6.27%
$12.38
KVUE +0.59%
$17.12
RGTI -4.97%
$26.81
CGC +2.67%
$1.16
SMR -4.59%
$20.34
SBET +4.88%
$11.60